(Q42552889)

2 November 2017

title

Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. (English)

1 reference

2 November 2017

1 reference

1 reference

Andoh TF

1

1 reference

2 November 2017

Burdmann EA

2

1 reference

2 November 2017

Fransechini N

3

1 reference

2 November 2017

Houghton DC

4

1 reference

2 November 2017

Bennett WM

5

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

2 November 2017

1 reference

2 November 2017

volume

50

1 reference

2 November 2017

issue

4

1 reference

2 November 2017

page(s)

1110-1117

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1996.417

2 November 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

The long-term course of cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Reduced erythrocyte and leukocyte magnesium is associated with cyclosporin treatment and hypertension in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Pathogenesis of cyclosporine-induced hypomagnesemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

FK 506 for liver, kidney, and pancreas transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Evidence that the inhibition of Na+/K(+)-ATPase activity by FK506 involves calcineurin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

The effect of rapamycin on kidney function in the Sprague-Dawley rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Identification of increased nitric oxide biosynthesis during pregnancy in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Functional and structural characteristics of experimental FK 506 nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Preclinical evaluation of a new potent immunosuppressive agent, rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Mechanisms of the endothelial toxicity of cyclosporin A. Role of nitric oxide, cGMP, and Ca2+

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Vascular mechanisms of cyclosporin-induced hypertension in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Immunophilin-sensitive protein phosphatase action in cell signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Arginine feeding modifies cyclosporine nephrotoxicity in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Magnesium deficiency: pathophysiologic and clinical overview

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.417

7 January 2021

Identifiers

DOI

10.1038/KI.1996.417

1 reference

2 November 2017

1 reference